Preclinical studies suggested that the activation of TWEAK/FN14 signaling pathway was involved in the pathogenesis of LN and that the inhibition of TWEAK could improve glomerulonephritis in murine models of lupus [13–15]. The gene discussed is TNFSF12; the disease is lobular neoplasia.